on007864
NEMAR copy of ds007864
You're viewing the NEMAR copy at v1.0.0.
Each OpenNeuro pull is a NEMAR major bump
(vN.0.0); intermediate versions are NEMAR-side fixes.
NEMAR DOI 10.82901/nemar.on007864
OpenNeuro DOI 10.18112/openneuro.ds007864.v1.0.0
Neuroepo multisession Phase II and III
Multisession EEG and clinical dataset from a randomized, placebo-controlled study of intranasal NeuroEPO (an erythropoietin formulation) in patients with Parkinson's disease. Participants were assessed at baseline and 9 months after the intervention, with cumulative NeuroEPO dose quantified and placebo coded as zero. The dataset supports analysis of treatment exposure, EEG-derived measures, and motor outcomes (MDS-UPDRS III).
EEG